Brief: Neurizon Therapeutics Raises A$5 Million At A$0.12 Per Share
18/09/2025 01:04
Sept 18 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: RAISES A$5 MILLION VIA INSTITUTIONAL PLACEMENT AT A$0.12 PER SHARE Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility